Lung Cancer Market Outlook 2018: Industry Insights, Top Companies Analysis, Business Overview and Upcoming Trends Forecast by 2025

Lung Cancer Market By Type (NSCLC and SCLC), Treatment (Photodynamic therapy (PDT), Laser Therapy, Radiotherapy, Surgery and Chemotherapy) and End User (Laboratories, Hospitals & Clinics and Cancer Research Centers) – Global Industry Analysis And Forecast To 2025

Lung Cancer Market : Industry Outlook
Lung Cancer is market is the cancer affecting the lungs, people having smoking habit are in great danger of getting affected, but also nonsmokers can also have a little risk of getting affected. Lung Cancer is the main cause for deaths in US, it is also responsible for claiming more lives that other cancers combined like prostate, ovarian, colon & breast cancer. Danger of getting affected by Lung Cancer depends on the number of cigarettes smoked & the length of smoking. Lung Cancer does not show any symptoms at initial stage, but as it advances it starts showing symptoms like; chest pain, shortness of breath, cough that is not treatable, headache, bone pain, weight loss, etc. Therefore, the Lung Cancer Market is anticipated to expand and has tremendous scope during the forecast period. The global Lung Cancer Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Access sample copy of this report

Market Segmentation
The global Lung Cancer Market is based on segment, by Type the market is segmented into NSCLC and SCLC, by Treatment the market is segmented into Photodynamic therapy (PDT), Laser Therapy, Radiotherapy, Surgery and Chemotherapy, and by End User the market is segmented into Laboratories, Hospitals & Clinics and Cancer Research Centers.

  • Lung Cancer Market, By Type
  • SCLC
  • Lung Cancer Market, By Treatment
  • Photodynamic therapy (PDT)
  • Laser Therapy
  • Radiotherapy
  • Surgery
  • Chemotherapy
  • Lung Cancer Market, By End User
  • Laboratories
  • Hospitals & Clinics
  • Cancer Research Centers

Regional Insights
On a global front, the Lung Cancer Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Lung Cancer Market, By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis
The leading players in the market are PFIZER INC., ELI Lilly and Company, F. Hoffmann-La Roche AG, Sanofi, BRISTOL-MYERS SQUIBB, Novartis and Merck & Co. Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • ELI Lilly and Company
  • F. Hoffmann-La Roche AG
  • Sanofi
  • Novartis
  • Merck & Co. Inc.

Browse Full Report With TOC @

Table of Contents:

Chapter1. Introduction

Chapter2. Executive Summary

Chapter3. Market Overview

Chapter4. Market Analysis by Regions

Chapter5. Lung Cancer Market, By Type

5.1. Introduction

5.2. Global Lung Cancer Revenue and Market Share by Type (2014-2018)

5.2.1. Global Lung Cancer Revenue and Revenue Share by Type (2014-2018)

5.3. NSCLC

5.3.1. Global NSCLC Revenue and Growth Rate (2014-2018)

5.4. SCLC

5.4.1. Global SCLC Revenue and Growth Rate (2014-2018)

Chapter6. Lung Cancer Market, By Treatment

6.1. Introduction

6.2. Global Lung Cancer Revenue and Market Share by Treatment (2014-2018)

6.2.1. Global Lung Cancer Revenue and Revenue Share by Treatment (2014-2018)

6.3. Photodynamic therapy (PDT)

6.3.1. Global Photodynamic therapy (PDT) Revenue and Growth Rate (2014-2018)

6.4. Laser Therapy

6.4.1. Global Laser Therapy Revenue and Growth Rate (2014-2018)

6.5. Radiotherapy

6.5.1. Global Radiotherapy Revenue and Growth Rate (2014-2018)

6.6. Surgery

6.6.1. Global Surgery Revenue and Growth Rate (2014-2018)

6.7. Chemotherapy

6.7.1. Global Chemotherapy Revenue and Growth Rate (2014-2018)


To avail discount, please click on the link @

About Crystal Market Research: 
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Crystal Market Research
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

%d bloggers like this: